Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,191 across all filing types
Latest filing 2026-03-06 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
114年第4季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial figures for the fiscal year 114 (Taiwan calendar year) and the fourth quarter. It includes revenue, costs, expenses, net income, and earnings per share data. The presence of actual financial data and detailed accounting items indicates this is a financial report rather than an announcement or summary. The document length is 2311 characters, which is relatively short but contains substantive financial data, so it is not merely a report publication announcement. The content matches the characteristics of an Interim / Quarterly Report (IR) as it covers a quarterly period with detailed financial statements.
2026-03-06 Chinese
114年第4季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for the fiscal year ending December 31, 2025 (114th year in the ROC calendar). It includes asset, liability, and equity breakdowns with monetary amounts and percentages. The document is 3176 characters long, which is relatively short but contains substantive financial data, not just an announcement or a link to a report. The presence of detailed financial statements for a specific quarter (fourth quarter of 2025) indicates this is a quarterly or interim financial report rather than a full annual report. There is no indication that this is an earnings release or a summary; it is a full financial statement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-03-06 Chinese
115年02月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tabular data about shareholdings of insiders, including directors, chairman, general manager, and their related parties. It lists share types, quantities held at different times, increases and decreases in holdings, and other related information. This type of document is characteristic of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but a detailed disclosure of insider shareholdings and changes. Therefore, the appropriate classification is Director's Dealing (DIRS).
2026-03-05 Chinese
115年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledges of shares by insiders, including directors, supervisors, and senior management of the company. It lists the number of shares held, pledged shares, and related percentages. The content is focused on insider shareholdings and their changes, which aligns with reporting of personal share transactions or holdings by company directors and executives. There is no indication of financial statements, earnings data, meeting materials, or regulatory announcements. The document is not a report publication announcement or a certification. Therefore, the document fits best into the category of Director's Dealing (DIRS).
2026-03-05 Chinese
公告本公司董事會決議召開115年股東常會
AGM Information Classification · 95% confidence The document is a public announcement from a company (神隆) regarding the board of directors' resolution to convene the Annual General Meeting (AGM) for the year 115 (Taiwanese calendar year). It includes details such as the date and location of the AGM, the agenda items including reports, approvals, and discussions to be held at the AGM. The document does not contain the actual AGM materials or reports but is an announcement about the AGM meeting itself. The document length is short (893 characters), and it serves as a notice of the AGM rather than the AGM report or presentation. Therefore, it fits the category of AGM Information (AGM-R).
2026-03-04 Chinese
公告本公司董事會決議股利分派
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement (766 characters) from a company (1789 神隆) disclosing the board of directors' resolution on dividend distribution for the fiscal year 114 (covering 114/01/01 to 114/12/31). It specifies cash dividend per share, total cash dividend amount, and confirms no stock dividends or capital increases. The document is an official notice of dividend amount and payment details, not a full financial report or annual report. It fits the definition of 'Notice of Dividend Amount' (DIV).
2026-03-04 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.